Login  |  Register
go Advanced Search

My Cart (0 items) Help

 

Canada (change)

   

HomeMedicine Hematology
 

Emerging Therapies Targeting the Pathophysiology of Sickle Cell Disease, An Issue of Hematology/Oncology Clinics

Elsevier Title
ISBN: 978-0-323-28999-3

Add to Cart
Check Out

Emerging Therapies Targeting the Pathophysiology of Sickle Cell Disease, An Issue of Hematology/Oncology Clinics

By Elliot Vichinsky, MD

Copyright 2014
$128.99, Hardcover, Reference

A title in the The Clinics: Internal Medicine Series.

Availability:This title is currently out of stock. We will ship as soon as we receive our stock.

 


Description

This issue of Hematology/Oncology Clinics, guest edited by Dr. Elliott Vichinsky, is devoted to Sickle Cell Disease, and focuses on pathophysiology of hemoglobinopathies, therapeutic targets, and new approaches to correcting ineffective erythropoiesis and iron dysregulation. Articles in this issue include Polymerization and red cell membrane changes; Overview on reperfusion injury in the pathophysiology of SCD; Regulation of ineffective erythropoiesis in iron metabolism; Altering oxygen affinity; Cellular adhesion and the endothelium; Arginine therapy; Role of the hemostatic system on SCD pathophysiology and potential therapeutics; Adenosine signaling and novel therapies; New approaches to correcting ineffective erythropoiesis and iron dysregulation; New approaches to correcting ineffective erythropoiesis and iron dysregulation; Fetal hemoglobin induction; Gene therapy for hemoglobinopathies; and Oxidative injury and the role of antioxidant therapy.

Author Information

By Elliot Vichinsky, MD

Sign up today

Free Shipping with Online Orders

Print this page